David Hallal is of iTeos Therapeutics, Inc.. Currently has a direct ownership of 0 shares of ITOS, which is worth approximately $0. The most recent transaction as insider was on Jun 09, 2022, when has been sold 1,171 shares (Common Stock) at a price of $19.51 per share, resulting in proceeds of $22,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

David Hallal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2022
SELL
Open market or private sale
$22,846 $19.51 p/Share
1,171 Reduced 100.0%
0 Common Stock
Jun 09 2022
BUY
Exercise of conversion of derivative security
$4,953 $4.23 p/Share
1,171 Added 50.0%
1,171 Common Stock
Jun 08 2022
SELL
Open market or private sale
$574,853 $20.21 p/Share
28,444 Reduced 100.0%
0 Common Stock
Jun 08 2022
BUY
Exercise of conversion of derivative security
$108,087 $3.8 p/Share
28,444 Added 72.89%
10,577 Common Stock
Dec 20 2021
SELL
Open market or private sale
$2,178,500 $43.57 p/Share
50,000 Reduced 100.0%
0 Common Stock
Dec 20 2021
BUY
Exercise of conversion of derivative security
$181,500 $3.63 p/Share
50,000 Added 50.0%
50,000 Common Stock

Also insider at

SEER
Seer, Inc. Healthcare
ALVR
Allovir, Inc. Healthcare
SRRK
Scholar Rock Holding Corp Healthcare
DH

David Hallal

Waltham, MA

Track Institutional and Insider Activities on ITOS

Follow iTeos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

News

Receive news related to iTeos Therapeutics, Inc.

Track Activities on ITOS